hi all below is a summary listing of medical article citations which contain references to Parkinson's disease [PD] and which have been added to the PubMed WWWeb site in the past 30 days at: <a href="http://www.ncbi.nlm.nih.gov/PubMed/"> http://www.ncbi.nlm.nih.gov/PubMed/</a> entering the PMID number in the search window there will take you to an abstract [synopsis] of the article [if one is available on-line] the full articles are accessible directly from the relevant medical journal maybe on the web [at a cost] or at a good library [at no cost] or maybe even at your own neurologist's office! education + titration R us janet ----------------------------------------------------------------------- pmid pubmed update june 2000 30 days 135 hits Spousal perspective of PD in middle life. J Adv Nurs. 2000 Jun;31(6):1409-1415. PMID: 10849153 L-glutamate, L-arginine and L-citrulline levels in PD, MSA, and AD patients. J Neural Transm. 2000;107(2):183-9. PMID: 10847559 Serum levels of coenzyme Q10 in patients with PD. J Neural Transm. 2000;107(2):177-81. PMID: 10847558 Monitoring of the levodopa concentration-response relationship in PD. Kao Hsiung I Hsueh Ko Hsueh Tsa Chih. 2000 Mar;16(3):117-25. PMID: 10846347 Glutathione depletion in PC12: implications for PD. J Biol Chem. 2000 Jun 8 [epub ahead of print] PMID: 10846169 The emergence of modern neuroscience: implications for neurology and psychiatry. Annu Rev Neurosci. 2000;23:343-91. PMID: 10845068 Non-Microelectrode Guided Stereotactic Pallidotomy for PD Stereotact Funct Neurosurg. 2000 Apr;72(2-4):245. No abstract available. PMID: 10844447 Stereotactic Posterioventral Pallidotomy Improves Balance Control Stereotact Funct Neurosurg. 2000 Apr;72(2-4):233-240. PMID: 10844445 Tremor Control and Thalamic DBS Electrode Placement and Macroelectrode Stimulation Stereotact Funct Neurosurg. 2000 Apr;72(2-4):225-232. PMID: 10844444 Outcomes and Complications of Fetal Tissue Transplantation in PD Stereotact Funct Neurosurg. 2000 Apr;72(2-4):219-224. PMID: 10844443 Tremor Rebound following Long-Term Chronic Thalamic Stimulation for PD and ET. Stereotact Funct Neurosurg. 2000 Apr;72(2-4):208-218. PMID: 10844442 Electrical Inhibition of Basal Ganglia Nuclei in PD: Long-Term Results. Stereotact Funct Neurosurg. 2000 Apr;72(2-4):202-207. PMID: 10844441 Subthalamic Stimulation in PD. preliminary results. Stereotact Funct Neurosurg. 2000 Apr;72(2-4):170-173. PMID: 10844435 Gastric electromechanical dysfunction in PD. Funct Neurol. 2000 Jan-Mar;15(1):41-6. PMID: 10842759 Calpain inhibitors as therapeutic agents in nerve and muscle degeneration. Ann N Y Acad Sci. 1999 Nov 28;884:52-9. PMID: 10842583 Movement Disorders in People With PD: A Model for Physical Therapy. Phys Ther. 2000 Jun;80(6):578-597. PMID: 10842411 Full length alpha-synuclein is present in PD and normal subjects. Neurosci Lett. 2000 Jun 16;287(1):65-67. PMID: 10841992 Long-Term Follow-up of Unilateral Pallidotomy in Advanced PD N Engl J Med. 2000 Jun 8;342(23):1708-1714. PMID: 10841873 Motor learning and PD: refinement of within-limb and between-limb coordination. Behav Brain Res. 2000 Jun 15;111(1-2):45-59. PMID: 10840131 N-myc and c-myc expression in AD, HD and PD. Brain Res Mol Brain Res. 2000 May 5;77(2):270-276. PMID: 10837922 A model of the PD visual system: support for the dark adaptation hypothesis. Vision Res. 2000 Jun 1;40(14):1937-1946. PMID: 10837836 A novel chemical delivery system for brain targeting. Adv Drug Deliv Rev. 1999 Apr 5;36(2-3):255-275. PMID: 10837719 A pharmacokinetic-pharmacodynamic approach to R-apomorphine delivery in PD. Adv Drug Deliv Rev. 1998 Sep 7;33(3):253-263. PMID: 10837665 Pharmacodynamic aspects of drug administration. Tolerance development. Adv Drug Deliv Rev. 1998 Sep 7;33(3):235-240. PMID: 10837663 Serotonin and amino acids: partners in delirium pathophysiology? Semin Clin Neuropsychiatry. 2000 Apr;5(2):125-31. PMID: 10837101 [Respiratory function impairment in PD: pathogenetic relation to autonomic dysfunction]. Rinsho Shinkeigaku. 2000 Feb;40(2):125-30. Japanese. PMID: 10835931 Mechanisms of antiapoptotic effects of estrogens in nigral dopaminergic neurons. FASEB J. 2000 Jun;14(9):1202-1214. PMID: 10834942 Coffee may lower risk of PD. BMJ. 2000 Jun 3;320(7248):1492A. No abstract available. PMID: 10834878 L-dopa side effects + dopamine metabolites + locomotor activities + dopamine binding Life Sci. 2000 Apr 21;66(22):2159-71. PMID: 10834300 [Usefulness and pitfalls in clinical electrophysiological studies]. J Cardiol. 2000 Mar;35 Suppl 1:3-9. Japanese. PMID: 10834163 Central motor conduction time in PD. J Clin Neurosci. 1999 Jan;6(1):17-19. PMID: 10833564 Impact of PD and its pharmacologic treatment on quality of life and economic outcomes. Am J Health Syst Pharm. 2000 May 15;57(10):953-62. PMID: 10832495 Redox reactions of neurotransmitters possibly involved in the progression of PD. J Inorg Biochem. 2000 Apr;79(1-4):319-26. PMID: 10830883 Hitler's diagnosis. J Nerv Ment Dis. 2000 May;188(5):311. No abstract available. PMID: 10830571 Clozapine replacement by quetiapine for drug-induced psychosis in PD. Mov Disord. 2000 May;15(3):579-81. No abstract available. PMID: 10830427 Parkinsonism, dystonia, and hemiatrophy. Mov Disord. 2000 May;15(3):537-41. PMID: 10830421 Motor initiation and execution in essential tremor and PD. Mov Disord. 2000 May;15(3):511-5. PMID: 10830417 Illness impact and adjustment to PD: before and after treatment with tolcapone. Mov Disord. 2000 May;15(3):497-502. PMID: 10830415 Gender differences in the frequency and treatment of behavior problems in PD. Mov Disord. 2000 May;15(3):490-6. PMID: 10830414 Withdrawal of levodopa/carbidopa and bromocriptine in early PD Mov Disord. 2000 May;15(3):485-9. PMID: 10830413 Differential progression of motor impairment in levodopa-treated PD. Mov Disord. 2000 May;15(3):479-84. PMID: 10830412 Early detection of PD: II. A prospective application of a diagnostic test battery. Mov Disord. 2000 May;15(3):474-8. PMID: 10830411 Early detection of PD: I. Development of a diagnostic test battery. Mov Disord. 2000 May;15(3):467-73. PMID: 10830410 Nigrostriatal denervation, parkinsonism, and dyskinesias in the MPTP primate model. Mov Disord. 2000 May;15(3):459-66. PMID: 10830409 Cost-effectiveness analysis in PD: determining the value of interventions. Mov Disord. 2000 May;15(3):439-45. No abstract available. PMID: 10830407 Scientific position paper of the Movement Disorder Society evaluation of surgery for PD. Mov Disord. 2000 May;15(3):436-8. No abstract available. PMID: 10830406 The politics and ethics of human embryo and stem cell research. Womens Health Issues. 2000 May 1;10(3):105-110. PMID: 10828544 The genetics of PD. Curr Opin Genet Dev. 2000 Jun;10(3):292-298. PMID: 10826990 Mobility in old age. Gerodontology. 1999 Dec;16(2):69-74. PMID: 10825844 Nuclear magnetic relaxation dispersion in PD patients consistent with protein aggregation. Neurochem Int. 2000 Oct 1;37(4):331-336. PMID: 10825573 Effects of a unilateral stereotaxic injection of Tinuvin 123 in the rat. Brain Res. 2000 Jun 2;866(1-2):197-210. PMID: 10825495 Overexpression of human alpha-synuclein causes dopamine neuron death in rat Brain Res. 2000 Jun 2;866(1-2):33-43. PMID: 10825478 Reduced dopamine transporters in REM sleep behaviour disorder: PD and controls compared Brain. 2000 Jun;123(Pt 6):1155-1160. PMID: 10825354 The impact of deep brain stimulation on executive function in PD. Brain. 2000 Jun;123(Pt 6):1142-1154. PMID: 10825353 Association between early-onset PD and mutations in the parkin gene. N Engl J Med. 2000 May 25;342(21):1560-7. PMID: 10824074 Alpha-synuclein cortical Lewy bodies correlate with dementia in PD. Neurology. 2000 May 23;54(10):1916-21. PMID: 10822429 The long-duration response to L-dopa in the treatment of early PD. Neurology. 2000 May 23;54(10):1910-5. PMID: 10822428 Response to L-dopa in PD: the long and the short of it. Neurology. 2000 May 23;54(10):1884-5. No abstract available. PMID: 10822422 Apoptosis mediated by oxidative stress + enhanced by cyanide in PC12 cells. J Neurochem. 2000 Jun;74(6):2296-304. PMID: 10820189 Association of coffee and caffeine intake with the risk of PD. JAMA. 2000 May 24-31;283(20):2674-9. PMID: 10819950 Non-NMDA receptor-mediated mechanisms in Parkinsonian rats. Synapse. 2000 Jun 15;36(4):267-74. PMID: 10819904 Similar breakdown of capillaries in AD, PD, and experimental hypertension. Ann N Y Acad Sci. 2000 Apr;903:72-82. Review. PMID: 10818491 Reflex excitability regulates prepulse inhibition. J Neurosci. 2000 Jun 1;20(11):4240-7. PMID: 10818160 Wild-type but not PD-related Ala53Thr-mutant [alpha] synuclein protect neuronal cells J Biol Chem. 2000 May 18 [epub ahead of print] PMID: 10818098 Essential fatty acids and the brain: possible health implications. Int J Dev Neurosci. 2000 Jul 1;18(4-5):383-399. PMID: 10817922 93: Green PS, Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action. Int J Dev Neurosci. 2000 Jul 1;18(4-5):347-358. PMID: 10817919 Inhibition of neuronal nitric oxide synthase protects against MPTP toxicity. Neuroreport. 2000 Apr 27;11(6):1265-8. PMID: 10817604 Tacrine, a reversible acetylcholinesterase inhibitor, induces myopathy. Neuroreport. 2000 Apr 27;11(6):1173-6. PMID: 10817586 Human tyrosine hydroxylase gene and phenotypic recovery in Parkinsonian rats. Neuroreport. 2000 Apr 27;11(6):1145-51. PMID: 10817582 PD mortality and pesticide exposure in California 1984-1994. Int J Epidemiol. 2000 Apr;29(2):323-9. PMID: 10817132 The pedunculopontine nucleus: its role in the genesis of movement disorders. Yonsei Med J. 2000 Apr;41(2):167-84. Review. PMID: 10817016 Cell replacement therapies for central nervous system disorders. Nat Neurosci. 2000 Jun;3(6):537-44. PMID: 10816308 A five-year study of ropinirole or levodopa and dyskinesia in early PD N Engl J Med. 2000 May 18;342(20):1484-91. PMID: 10816186 How patients with PD retrieve and manage cognitive event knowledge. Cortex. 2000 Apr;36(2):163-79. PMID: 10815704 Levodopa-treated PD has better long-term outcome than previously predicted. Arch Neurol. 2000 May;57(5):758-9. No abstract available. PMID: 10815149 Clinical characteristics of pramipexole-induced peripheral edema. Arch Neurol. 2000 May;57(5):729-32. PMID: 10815140 Receptors in neurodegenerative diseases. Pharm Acta Helv. 2000 Mar;74(2-3):247-51. PMID: 10812965 Excitatory amino acid agonists and antagonists: pharmacology and applications. Pharm Acta Helv. 2000 Mar;74(2-3):221-9. PMID: 10812962 Altinicline (SIB-1508Y), a novel acetylcholine-gated ion channel (nAChR) agonist. Pharm Acta Helv. 2000 Mar;74(2-3):125-30. PMID: 10812948 Nicotinic systems in CNS disease: degenerative disorders and beyond. Pharm Acta Helv. 2000 Mar;74(2-3):91-101. PMID: 10812945 Energetic adaptation to chronic disease in the elderly. Nutr Rev. 2000 Mar;58(3 Pt 1):61-6. Review. PMID: 10812919 Dopamine agonists: their role in the treatment of PD. J Neurol Neurosurg Psychiatry. 2000 Jun;68(6):685-9. No abstract available. PMID: 10811688 Porcine xenografts in PD and HD: preliminary results. Cell Transplant. 2000 Mar-Apr;9(2):273-8. PMID: 10811399 Intrastriatal ventral mesencephalic xenografts of porcine tissue in rats Cell Transplant. 2000 Mar-Apr;9(2):261-72. PMID: 10811398 Embryonic mesencephalic, dopaminergic tissue grafted to a mini-pig model of PD Cell Transplant. 2000 Mar-Apr;9(2):247-59. PMID: 10811397 Neural tissue xenotransplantation: what is needed prior to clinical trials in PD? Cell Transplant. 2000 Mar-Apr;9(2):235-46. PMID: 10811396 Implication of the subthalamic nucleus in the pathophysiology and pathogenesis of PD. Cell Transplant. 2000 Mar-Apr;9(2):215-21. PMID: 10811394 Behavioral changes after terminal striatal 6-OHDA lesion and transplantation of dopaminergic embryonic micrografts. Cell Transplant. 2000 Mar-Apr;9(2):197-214. PMID: 10811393 Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant. 2000 Mar-Apr;9(2):179-95. PMID: 10811392 Sleep and periodic leg movement patterns in drug-free patients with PD and MSA. Sleep. 2000 May 1;23(3):361-7. PMID: 10811380 The activity of COMT in PD patients with "on-off fluctuations". J Neural Transm. 2000;107(1):105-11. PMID: 10809408 Effects of apomorphine on visual functions in PD. J Neural Transm. 2000;107(1):87-94. PMID: 10809406 Risk factors for dementia, depression and psychosis in long-standing PD. J Neural Transm. 2000;107(1):59-71. PMID: 10809404 Altered redox state of platelet coenzyme Q10 in PD. J Neural Transm. 2000;107(1):41-8. PMID: 10809402 Involvement of alpha-synuclein in PD and other neurodegenerative disorders. J Neural Transm. 2000;107(1):31-40. PMID: 10809401 Cell death mechanisms in PD. J Neural Transm. 2000;107(1):1-29. PMID: 10809400 janet paterson 53 now / 41 dx / 37 onset 613 256 8340 / PO Box 171 Almonte Ontario K0A 1A0 Canada visit my website "a new voice" at: "http://www.geocities.com/janet313/"